Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

allogeneic natural killer cells PB103

A preparation of allogeneic, natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon administration, allogeneic NK cells PB103 may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic NK Cells PB103
allogeneic NKs PB103
Code name:PB 103
PB-103
PB103
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search